What's the most recent regulatory action in Administration of Local Anesthetic Nerve Block?

Most recent: Bupivacaine Hydrochloride And Epinephrine — FDA approved.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/administration-of-local-anesthetic-nerve-block.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Administration of Local Anesthetic Nerve Block — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Administration of Local Anesthetic Nerve Block (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Administration of Local Anesthetic Nerve Block, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Carbocaine	MEPIVACAINE	Eastman Kodak	Amide Local Anesthetic	Sodium channel protein type 1 subunit alpha	1960-01-01
Epipen	epinephrine	Pfizer Inc.	alpha-Adrenergic Agonist [EPC]	Alpha-1D adrenergic receptor	1948-01-01
Epinephrin	Epinephrin	United States Naval Medical Center, San Diego		Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor
Carbocaine	Carbocaine	Nantes University Hospital		Sodium channel protein type 1 subunit alpha, Sodium channel protein type 2 subunit alpha, Sodium channel protein type 3 subunit alpha

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

2026-03-30 — Bupivacaine Hydrochloride And Epinephrine · FDA · approved · US

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer Inc. · 2 drugs in Administration of Local Anesthetic Nerve Block
· 1 drug in Administration of Local Anesthetic Nerve Block
Eastman Kodak · 1 drug in Administration of Local Anesthetic Nerve Block
Nantes University Hospital · 1 drug in Administration of Local Anesthetic Nerve Block
United States Naval Medical Center, San Diego · 1 drug in Administration of Local Anesthetic Nerve Block

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Administration of Local Anesthetic Nerve Block:

Cite this brief

Drug Landscape (2026). Administration of Local Anesthetic Nerve Block — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/administration-of-local-anesthetic-nerve-block. Accessed 2026-06-10.

Administration of Local Anesthetic Nerve Block full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing